Dan LeBatard offers the most intelligent and mature take on PEDs in sports I’ve seen in ages. He asks us to take a step back and ask ourselves why it is we are so hung up on a certain, narrow kind of performance enhancement in sports when we never question it — indeed, we openly praise it — when athletes do insane things to their bodies, all in the name of staying on the field? Often things that could cause massive harm.
Stuff like Ronnie Lott cutting his finger off. Lomas Brown playing with a catheter. Players having ligaments taken from cadavers and inserted into their own bodies. Drug therapies and medical procedures that are wholly unnecessary for a normal quality of life but are accepted in the name of athletic performance. We are totally fine with these. We are not totally fine with others:
We are OK with Kirk Gibson hitting one of the most famous home runs ever on one steroid (cortisone), but we slam the Hall of Fame door on the face of everybody else who might have used the anabolic kind. Granted, cortisone is not a banned performance enhancer, but it certainly enhanced Gibson’s performance, which wouldn’t have been possible without it. Lost in the shouting of “Cheater!” and “Fraud!” from a pill-popping America is how often athletes have to go through the pharmacy for the healing properties of hormones — not just to hit home runs but because what they do for a daily living really hurts.
It is not enough to draw some line and say “well, [drug/procedure X] is banned and [drug/procedure Y] is not banned.” It makes people who like to pour crap on banned PED users feel better, but it’s a most pedantic distinction. Why are some procedures and drugs banned and others not? Why do we allow some sorts of performance enhancement or enabling but not others? If it’s OK for Kirk Gibson to take a drug that allowed him to take the field when he otherwise could not have, why do we not allow other players to take other drugs that allow them to take the field when they otherwise can’t?
More broadly, as fans and observers, why do we seem to care so much and get so annoyed at certain sorts of seemingly unnatural acts undertaken by athletes but don’t care a bit — or, alternatively, fully expect — so many others?
Evan Drellich of the Houston Chronicle shares the bad news …
One of the Astros’ big bats won’t be taking hacks when the Astros hold their first full workout on Feb. 23.
Astros designated hitter Evan Gattis recently underwent surgery to repair a hernia, the Chronicle has learned, taking away most of his spring training at a minimum. The recovery is four to six weeks but fortunately for Gattis and the Astros, the injury is not considered severe.
Gattis was working hard on his overall conditioning this winter, even telling MLB.com’s Brian McTaggart in late January that he had already dropped 18 pounds. It sounds like the big slugger might have gone a bit overboard with those workouts, and now he is in real danger of missing the first couple weeks of the 2016 regular season.
Gattis batted .246/.285/.463 with 27 home runs and 88 RBI in 153 games last season for the Astros. The 29-year-old is arbitration-eligible for the first time in his career and has a hearing with the Astros scheduled for February 16 to determine his salary for 2016. He requested $3.8 million and was offered $3 million when figures were exchanged a little over three weeks ago.
Suddenly the Astros’ front office might have a new talking point for those arbitrators.
At last check, new Cardinals reliever Seung-Hwan Oh was still awaiting a work visa from the United States Embassy in South Korea and there was some worry that he might not be able to arrive on time to spring training in Jupiter, Florida.
But that is now officially a non-story.
Derrick Goold of the St. Louis Post-Dispatch reports that Oh has recieved his work visa and is expected to report to Cardinals camp next week along with the rest of the club’s pitchers and catchers. Oh might even show up a bit earlier than the Cardinals originally asked him to, per Goold.
Oh saved 357 games in 11 seasons between Japan’s Nippon Professional Baseball and the Korea Baseball Organization before inking a one-year contract with St. Louis this winter. He also registered a stellar 1.81 ERA and 772 strikeouts across 646 total innings in Asia, earning the nickname “The Final Boss.”
Oh is expected to work in a setup role this year for Cardinals closer Trevor Rosenthal.
John Lamb was part of the Reds’ return package in last July’s Johnny Cueto trade and he had a strong showing at the Triple-A level in 2015. But the young left-hander posted a 5.80 ERA in a 10-start cup of coffee with Cincinnati late last season — his first 10 appearances as a major leaguer — and now comes word from MLB.com’s Mark Sheldon that Lamb will probably have to get off to a late start in 2016.
Lamb underwent surgery in December to repair a herniated disc in his back — a surgery that went unreported by the Reds until Tuesday afternoon. Reds manager Bryan Price acknowledged on MLB Network that Lamb is behind the team’s other starting pitchers and will likely open the coming season on the disabled list. The hope is that he might be ready by mid-April.
It’s a small but frustrating blow for a rebuilding Reds team that will be looking to establish some foundational pieces in 2016. Once he is recovered, Lamb will be expected to fill the Reds’ fifth rotation spot behind Raisel Iglesias, Anthony DeSclafani, Brandon Finnegan, and Michael Lorenzen.
This is going to be an ugly year for Cincinnati baseball fans.
Rangers ace Yu Darvish missed the entire 2015 season after undergoing Tommy John reconstructive elbow surgery last March 17. Most starting pitchers take 13-15 months to fully recover from that procedure, and the Rangers aren’t counting on Darvish until sometime this May.
His rehab so far has gone on without issue.
Darvish offered some very positive updates Tuesday to Jeff Wilson of the Fort Worth Star-Telegram …
Darvish, 29, boasts a 3.27 ERA and 1.196 WHIP in 83 career major league starts. He can also claim a whopping 680 strikeouts in 545 1/3 career major league innings.
Texas has him under contract for $10 million in 2016 and $11 million in 2017.